| Broad and potent neutralization of HIV-1 by a gp41-specific human antibody J Huang, G Ofek, L Laub, MK Louder, NA Doria-Rose, NS Longo, ... Nature 2012, 491(7424):406-12, 2012 | 971 | 2012 |
| Structure and immune recognition of trimeric pre-fusion HIV-1 Env M Pancera, T Zhou, A Druz, IS Georgiev, C Soto, J Gorman, J Huang, ... Nature 514 (7523), 455-461, 2014 | 825 | 2014 |
| Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications F Wu, A Wang, M Liu, Q Wang, J Chen, S Xia, Y Ling, Y Zhang, J Xun, ... MedRxiv, 2020 | 796 | 2020 |
| Broad and potent HIV-1 neutralization by a human antibody that binds the gp41–gp120 interface J Huang, BH Kang, M Pancera, JH Lee, T Tong, Y Feng, H Imamichi, ... Nature 515 (7525), 138-142, 2014 | 504 | 2014 |
| Identification of a CD4-binding-site antibody to HIV that evolved near-pan neutralization breadth J Huang, BH Kang, E Ishida, T Zhou, T Griesman, Z Sheng, F Wu, ... Immunity 45 (5), 1108-1121, 2016 | 344 | 2016 |
| Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody R Kong, K Xu, T Zhou, P Acharya, T Lemmin, K Liu, G Ozorowski, C Soto, ... Science 352 (6287), 828-833, 2016 | 327 | 2016 |
| Assessment of variability in the SOMAscan assay J Candia, F Cheung, Y Kotliarov, G Fantoni, B Sellers, T Griesman, ... Scientific reports 7 (1), 14248, 2017 | 293 | 2017 |
| Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor A Pegu, Z Yang, JC Boyington, L Wu, SY Ko, SD Schmidt, K McKee, ... Science translational medicine 6 (243), 243ra88-243ra88, 2014 | 251 | 2014 |
| Evaluating the association of clinical characteristics with neutralizing antibody levels in patients who have recovered from mild COVID-19 in Shanghai, China F Wu, M Liu, A Wang, L Lu, Q Wang, C Gu, J Chen, Y Wu, S Xia, Y Ling, ... JAMA internal medicine 180 (10), 1356-1362, 2020 | 239 | 2020 |
| CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21 H Chen, C Li, J Huang, T Cung, K Seiss, J Beamon, MF Carrington, ... The Journal of clinical investigation 121 (4), 1549-1560, 2011 | 207 | 2011 |
| Isolation of human monoclonal antibodies from peripheral blood B cells J Huang, NA Doria-Rose, NS Longo, L Laub, CL Lin, E Turk, BH Kang, ... Nature protocols 8 (10), 1907-1915, 2013 | 175 | 2013 |
| Characterization of immunity induced by M2e of influenza virus F Wu, JH Huang, XY Yuan, WS Huang, YH Chen Vaccine 25 (52), 8868-8873, 2007 | 113 | 2007 |
| Immune perturbations in HIV-1–infected individuals who make broadly neutralizing antibodies MA Moody, I Pedroza-Pacheco, NA Vandergrift, C Chui, KE Lloyd, ... Science immunology 1 (1), aag0851-aag0851, 2016 | 105 | 2016 |
| Telomerase activity of HIV-1–specific CD8+ T cells: constitutive up-regulation in controllers and selective increase by blockade of PD ligand 1 in progressors M Lichterfeld, D Mou, TDH Cung, KL Williams, MT Waring, J Huang, ... Blood, The Journal of the American Society of Hematology 112 (9), 3679-3687, 2008 | 100 | 2008 |
| Leukocyte immunoglobulin-like receptors maintain unique antigen-presenting properties of circulating myeloid dendritic cells in HIV-1-infected elite controllers J Huang, PS Burke, TDH Cung, F Pereyra, I Toth, BD Walker, L Borges, ... Journal of virology 84 (18), 9463-9471, 2010 | 86 | 2010 |
| HLA-B* 35-Px–mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses J Huang, JJ Goedert, EJ Sundberg, TDH Cung, PS Burke, MP Martin, ... Journal of Experimental Medicine 206 (13), 2959-2966, 2009 | 85 | 2009 |
| Optimization of the solubility of HIV-1-neutralizing antibody 10E8 through somatic variation and structure-based design YD Kwon, IS Georgiev, G Ofek, B Zhang, M Asokan, RT Bailer, A Bao, ... Journal of virology 90 (13), 5899-5914, 2016 | 77 | 2016 |
| Soluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2 J Huang, P Burke, Y Yang, K Seiss, J Beamon, T Cung, I Toth, F Pereyra, ... Journal of virology 84 (20), 10784-10791, 2010 | 68 | 2010 |
| Antibody-dependent enhancement (ADE) of SARS-CoV-2 infection in recovered COVID-19 patients: studies based on cellular and structural biology analysis F Wu, R Yan, M Liu, Z Liu, Y Wang, D Luan, K Wu, Z Song, T Sun, Y Ma, ... MedRxiv, 2020.10. 08.20209114, 2020 | 62 | 2020 |
| Surface exposure of the HIV-1 env cytoplasmic tail LLP2 domain during the membrane fusion process: interaction with gp41 fusion core L Lu, Y Zhu, J Huang, X Chen, H Yang, S Jiang, YH Chen Journal of biological chemistry 283 (24), 16723-16731, 2008 | 53 | 2008 |
